Document Detail


Thrombotest mixing experiments in congenital coagulation disorders of the prothrombin complex and in coumarin treated patients. An additional evidence against the presence of an inhibitor in the latter.
MedLine Citation:
PMID:  72033     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Thrombotest clotting times of mixtures of coumarin plasmas and normal plasma yielded a patterm similar to that observed in mixtures of plasma with congenital coagulation disorders and normal plasma. The presence of 10 or 20% of test plasma in the mixture failed to affect the clotting times which resulted in normal limits. The only exception to this rule was the hemophilia BM plasma. In this case even the presence of 10-20% of patient plasma in the mixture caused a prolongation of the clotting time. This indicates that no inhibitor is present in coumarin plasmas and in the plasma of congenital coagulation disorders of the prothrombin complex save for hemophilia BM plasma which does contain an inhibitor.
Authors:
A Girolami; O Patrassi; G Cella
Related Documents :
21936673 - The thyroid hormone degrading type 3 deiodinase is the primary deiodinase active in mur...
22749113 - Biomarkers of perchlorate exposure are correlated with circulating thyroid hormone leve...
7583563 - Relations between plasma lipids and postheparin plasma lipases and vldl and ldl subfrac...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Folia haematologica (Leipzig, Germany : 1928)     Volume:  104     ISSN:  0323-4347     ISO Abbreviation:  Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch.     Publication Date:  1977  
Date Detail:
Created Date:  1977-12-29     Completed Date:  1977-12-29     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0374615     Medline TA:  Folia Haematol Int Mag Klin Morphol Blutforsch     Country:  GERMANY, EAST    
Other Details:
Languages:  eng     Pagination:  463-70     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acenocoumarol / pharmacology*
Blood Coagulation*
Blood Coagulation Disorders / pathology*
Blood Coagulation Tests / methods
Female
Hemophilia B / pathology
Humans
Male
Prothrombin
Thromboplastin
Warfarin / pharmacology
Chemical
Reg. No./Substance:
152-72-7/Acenocoumarol; 81-81-2/Warfarin; 9001-26-7/Prothrombin; 9035-58-9/Thromboplastin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Studies on families with Osler's disease
Next Document:  Structural proteins of C-type RNA tumor viruses. Properties and significance for tumor immunity